Login
Cart
Support
Search
Search
Search
Home
eSymposia
ePanels
SciTalks
Virtual Recaps
Event Summary
Register for On Demand
Sessions
More
Support
Preferred
(EDT)
Emerging Therapies for NASH
10:00 AM - 1:25 PM EDT
Wednesday, March 24, 2021
Room: Multi Tech Session
Archive
Co-Chairs
Hannele Yki-Järvinen
,
MD, PhD
University of Helsinki
Morris Birnbaum
,
MD, PhD
Pfizer Inc.
Other
Emerging Therapies for NASH
DGAT2 Inhibition for NASH
10:00 AM - 10:25 AM EDT
Wednesday, March 24, 2021
Room: V400 Ryan Reid
Archive
Speaker
Morris Birnbaum
, MD, PhD
Pfizer Inc.
Emerging Therapies for NASH
Combination Therapies for NASH Cirrhosis
10:25 AM - 10:50 AM EDT
Wednesday, March 24, 2021
Room: V400 Ryan Reid
Archive
Speaker
Chuhan Chung
, MD
Gilead Sciences
Emerging Therapies for NASH
[NOT AVAILABLE ON DEMAND] Role of ATP Citrate Lyase (ACLY) in NASH and HCC
10:50 AM - 11:15 AM EDT
Wednesday, March 24, 2021
Room: V400 Ryan Reid
Speaker
Greg Steinberg
, PhD
McMaster University
Emerging Therapies for NASH
Inhibition of Fructose Metabolism for the Treatment of NAFLD
11:15 AM - 11:40 AM EDT
Wednesday, March 24, 2021
Room: V400 Ryan Reid
Archive
Speaker
Kendra Bence
, PhD
Pfizer Inc.
Emerging Therapies for NASH
Coffee Break
11:40 AM - 11:50 AM EDT
Wednesday, March 24, 2021
Emerging Therapies for NASH
Therapeutic FGF19 in Non-Alcoholic Steatohepatitis
11:50 AM - 12:15 PM EDT
Wednesday, March 24, 2021
Room: V200 Ronney Laws
Archive
Speaker
Lei Ling
, PhD
NGM Biopharmaceuticals
Emerging Therapies for NASH
Short Talk: A Drug-Like Sphingolipid Opposes Mitochondrial Fragmentation and Corrects the Metabolic Sequelae of Obesity
12:15 PM - 12:30 PM EDT
Wednesday, March 24, 2021
Room: V200 Ronney Laws
Archive
Speaker
Aimee Edinger
, PhD
University of California, Irvine
Emerging Therapies for NASH
Short Talk: Inhibition of Hepatocyte Inflammasome Improves Features of NASH in foz/foz Mice
12:30 PM - 12:45 PM EDT
Wednesday, March 24, 2021
Room: V200 Ronney Laws
Archive
Speaker
Brian Rady
Janssen R&D
Emerging Therapies for NASH
Short Talk: Development of Liver-Targeted Interleukin-22 for Fatty Liver Disease
12:45 PM - 1:00 PM EDT
Wednesday, March 24, 2021
Room: V200 Ronney Laws
Archive
Speaker
Haressh Sajiir
University of Queensland - Mater Research Institute
Emerging Therapies for NASH
Short Talk: HHcy is a Feature and Mediator of NASH that Permits B12 and Folate to be an Effective Therapy for NASH
1:00 PM - 1:15 PM EDT
Wednesday, March 24, 2021
Room: V200 Ronney Laws
Archive
Speaker
Madhulika Tripathi
, PhD
Duke-NUS Medical School Singapore
Emerging Therapies for NASH
Closing Remarks
1:15 PM - 1:25 PM EDT
Wednesday, March 24, 2021
Room: V200 Ronney Laws
Archive
Emerging Therapies for NASH
×
Evaluation
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by
clicking here
.
Close this Window